Barbara Seitz‐Polski

3.8k total citations · 1 hit paper
62 papers, 2.2k citations indexed

About

Barbara Seitz‐Polski is a scholar working on Nephrology, Pathology and Forensic Medicine and Infectious Diseases. According to data from OpenAlex, Barbara Seitz‐Polski has authored 62 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Nephrology, 20 papers in Pathology and Forensic Medicine and 16 papers in Infectious Diseases. Recurrent topics in Barbara Seitz‐Polski's work include Renal Diseases and Glomerulopathies (29 papers), SARS-CoV-2 and COVID-19 Research (13 papers) and Autoimmune Bullous Skin Diseases (13 papers). Barbara Seitz‐Polski is often cited by papers focused on Renal Diseases and Glomerulopathies (29 papers), SARS-CoV-2 and COVID-19 Research (13 papers) and Autoimmune Bullous Skin Diseases (13 papers). Barbara Seitz‐Polski collaborates with scholars based in France, United States and Italy. Barbara Seitz‐Polski's co-authors include Vincent Esnault, Gérard Lambeau, Sylvia Benzaken, Guillaume Dolla, Vesna Brglez, Elion Hoxha, Rolf A.K. Stahl, Laurence H. Beck, Nicola M. Tomas and Anne-Sophie Dabert-Gay and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Kidney International.

In The Last Decade

Barbara Seitz‐Polski

57 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy

2014 641 citations Nicola M. Tomas, Barbara Seitz‐Polski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Seitz‐Polski France	22	1.5k	689	627	408	290	62	2.2k
Véronique Baudouin France	26	994 0.7×	343 0.5×	244 0.4×	467 1.1×	332 1.1×	84	1.9k
Meryl Waldman United States	19	839 0.6×	303 0.4×	295 0.5×	303 0.7×	190 0.7×	36	1.5k
Christiane Mousson France	22	795 0.5×	213 0.3×	407 0.6×	564 1.4×	251 0.9×	81	1.8k
Sylvia Benzaken France	21	490 0.3×	308 0.4×	265 0.4×	247 0.6×	187 0.6×	50	1.5k
Federico Alberici Italy	22	384 0.3×	197 0.3×	783 1.2×	345 0.8×	245 0.8×	86	2.0k
Michael Venning United Kingdom	17	970 0.7×	201 0.3×	782 1.2×	538 1.3×	240 0.8×	44	1.9k
Wolfram J. Jabs Germany	21	208 0.1×	368 0.5×	389 0.6×	450 1.1×	218 0.8×	40	1.8k
Mayumi Sako Japan	21	1.3k 0.9×	525 0.8×	192 0.3×	214 0.5×	235 0.8×	59	1.5k
Giles Walters Australia	18	439 0.3×	183 0.3×	330 0.5×	775 1.9×	197 0.7×	49	1.7k
Carlos E. Araya United States	19	651 0.4×	199 0.3×	152 0.2×	198 0.5×	107 0.4×	30	1.1k

Countries citing papers authored by Barbara Seitz‐Polski

Since Specialization

Citations

This map shows the geographic impact of Barbara Seitz‐Polski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Seitz‐Polski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Seitz‐Polski more than expected).

Fields of papers citing papers by Barbara Seitz‐Polski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Seitz‐Polski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Seitz‐Polski. The network helps show where Barbara Seitz‐Polski may publish in the future.

Co-authorship network of co-authors of Barbara Seitz‐Polski

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Seitz‐Polski. A scholar is included among the top collaborators of Barbara Seitz‐Polski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Seitz‐Polski. Barbara Seitz‐Polski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teisseyre, Maxime, Alexandre Destère, Marion Crémoni, et al.. (2025). Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial. BMJ Open. 15(4). e093920–e093920.

Teisseyre, Maxime, Marco Allinovi, Vincent Audard, et al.. (2024). Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies. Kidney International Reports. 10(3). 753–761. 8 indexed citations

Levraut, Michaël, et al.. (2023). Diagnostic significance of antineutrophil cytoplasmic antibody (ANCA) titres: a retrospective case-control study. RMD Open. 9(2). e003113–e003113. 3 indexed citations

Levraut, Michaël, Mikaël Cohen, Saskia Bresch, et al.. (2023). Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes. Neurology Neuroimmunology & Neuroinflammation. 10(6). 21 indexed citations

Teisseyre, Maxime, Vesna Brglez, Marion Crémoni, et al.. (2023). Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy. Clinical Journal of the American Society of Nephrology. 18(6). 785–787. 10 indexed citations

Lazareth, Hélène, Adrien Flahault, Vesna Brglez, et al.. (2023). Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors. Kidney International Reports. 8(9). 1892–1898.

Crémoni, Marion, Maxime Teisseyre, Kévin Zorzi, et al.. (2022). Toxic Occupational Exposures and Membranous Nephropathy. Clinical Journal of the American Society of Nephrology. 17(11). 1609–1619. 12 indexed citations

Crémoni, Marion, Kévin Zorzi, Maxime Teisseyre, et al.. (2022). Low baseline IFN-γ response could predict hospitalization in COVID-19 patients. Frontiers in Immunology. 13. 953502–953502. 20 indexed citations

Occelli, Céline, Jean‐Marie Guigonis, Sabine Lindenthal, et al.. (2022). Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19. Frontiers in Medicine. 9. 995069–995069. 10 indexed citations

10.

Barrière, Jérôme, Michel Carlès, Daniel Ré, et al.. (2021). Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article. European Journal of Cancer. 162. 182–193. 29 indexed citations

11.

Crémoni, Marion, Kévin Zorzi, Sonia Boyer‐Suavet, et al.. (2021). Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study. Frontiers in Medicine. 7. 608804–608804. 7 indexed citations

12.

Ghiggeri, Gian Marco, Barbara Seitz‐Polski, Joana Justino, et al.. (2020). Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy. Clinical Journal of the American Society of Nephrology. 15(12). 1762–1776. 21 indexed citations

13.

Brglez, Vesna, Sonia Boyer‐Suavet, Kévin Zorzi, et al.. (2020). Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial. Frontiers in Medicine. 7. 412–412. 6 indexed citations

14.

Boyer‐Suavet, Sonia, Marine Andreani, Vesna Brglez, et al.. (2020). Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab. Frontiers in Immunology. 10. 3069–3069. 74 indexed citations

15.

Vassallo, Matteo, et al.. (2020). Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation. International Journal of Infectious Diseases. 101. 174–179. 15 indexed citations

16.

Justino, Joana, Vesna Brglez, Guillaume Dolla, et al.. (2019). SaO027FROM NEW EPITOPE IDENTIFICATION TO PERSONALIZED MEDICINE IN PLA2R1-RELATED MEMBRANOUS NEPHROPATHY. Nephrology Dialysis Transplantation. 34(Supplement_1). 1 indexed citations

17.

Lebrun‐Frénay, Christine, Mikaël Cohen, Maria Alessandra Rosenthal‐Allieri, et al.. (2018). Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders. Neurology and Therapy. 7(2). 373–383. 31 indexed citations

18.

Seitz‐Polski, Barbara, Guillaume Dolla, Christine Payré, et al.. (2015). Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy. Biochimie. 118. 104–115. 16 indexed citations

19.

Dähnrich, Cornelia, Lars Komorowski, Christian Probst, et al.. (2013). Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clinica Chimica Acta. 421. 213–218. 101 indexed citations

20.

Rekima, Akila, Barbara Seitz‐Polski, Akira Kanda, et al.. (2010). Breast milk immune complexes are potent inducers of oral tolerance in neonates and prevent asthma development. Mucosal Immunology. 3(5). 461–474. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact